Longboard pharmaceuticals provides corporate update and reports second quarter 2021 financial results

San diego, aug. 09, 2021 (globe newswire) -- longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported financial results for the second quarter ended june 30, 2021.
LBPH Ratings Summary
LBPH Quant Ranking